JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders

被引：0
|
作者：
N Cambier
A Renneville
T Cazaentre
V Soenen
C Cossement
S Giraudier
N Grardel
J-L Laï
C Rose
C Preudhomme
机构：
[1] Service d'Hématologie Clinique,
[2] Groupe Hospitalier de l'Institut Catholique Lillois (GHICL),undefined
[3] Hôpital Saint-Vincent,undefined
[4] Unité 837,undefined
[5] INSERM,undefined
[6] Institut de Recherche sur le Cancer de Lille,undefined
[7] and North West Cancéropole,undefined
[8] Laboratoire d'Hématologie,undefined
[9] Centre de Biologie-Pathologie,undefined
[10] CHRU de Lille,undefined
[11] Laboratoire d'Hématologie,undefined
[12] Assistance Publique-Hôpitaux Paris (AP-HP),undefined
[13] Hôpital Henri Mondor and Université Paris XII,undefined
[14] Laboratoire de Cytogénétique,undefined
[15] Hôpital Jeanne de Flandres,undefined
[16] CHRU de Lille,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1454 / 1455
页数：1
相关论文
共 50 条
  • [41] Emergence of BCR-ABL1 Chronic Myeloid Leukemia in a JAK2-V617F Polycythemia Vera
    Lorenzo, Mariana
    Grille, Sofia
    Stevenazzi, Mariana
    JOURNAL OF HEMATOLOGY, 2020, 9 (1-2) : 23 - 29
  • [42] B-cell acute lymphoblastic leukemia in JAK2 V617F-positive polycythemia vera
    Jaitly, Vanya
    Wang, Wei
    BLOOD, 2018, 131 (08) : 941 - 941
  • [43] Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms
    L Bernard
    C Belisle
    L Mollica
    S Provost
    D-C Roy
    D G Gilliland
    R L Levine
    L Busque
    Leukemia, 2009, 23 : 287 - 291
  • [44] Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm
    Abedi, Elham
    Karimi, Mehran
    Cohan, Nader
    Haghpanah, Sezaneh
    Yaghobi, Ramin
    Azarpira, Negar
    Moghadam, Mohamad
    Bayat, Elahe
    Farokhian, Farnoush
    Mohammadi, Hamid
    Lak, Elahe Razmara
    Golafshan, Habib Allah
    Ramzi, Mani
    GALEN MEDICAL JOURNAL, 2021, 10
  • [45] Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms
    Bernard, L.
    Belisle, C.
    Mollica, L.
    Provost, S.
    Roy, D-C
    Gilliland, D. G.
    Levine, R. L.
    Busque, L.
    LEUKEMIA, 2009, 23 (02) : 287 - 291
  • [46] Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia
    Chen, Runzhe
    Wang, Fei
    Zhang, Xiaoping
    Gao, Chong
    Chen, Baoan
    OncoTargets and Therapy, 2015, 8 : 955 - 957
  • [47] Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes
    Hijiya, Nobuko
    Mauro, Michael J.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 873 - 891
  • [48] Chorea Associated with JAK2V617F-Positive Essential Thrombocythemia
    Calculli, Alessandra
    Arceri, Sebastiano
    Pisani, Antonio
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (01): : 154 - 155
  • [49] PONATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Narayanan, V.
    Pollyea, D. A.
    Gutman, J. A.
    Jimeno, A.
    DRUGS OF TODAY, 2013, 49 (04) : 261 - 269
  • [50] Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    McCormack, Paul L.
    Keam, Susan J.
    BIODRUGS, 2012, 26 (01) : 61 - 64
12345